StonvexLoading…
StonvexStonvexStonvexCore line items from VAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.90M | $9.60M | $8.40M | $9.20M |
Operating Income | $477.00M | $352.30M | $53.50M | $37.20M |
Net Income | $982.80M | $373.40M | $865.40M | $176.50M |
EPS (Diluted) | $13.86 | $5.12 | $11.51 | $2.33 |
Total Assets | $5.30B | $4.42B | $4.32B | $2.86B |
Total Liabilities | $2.13B | $2.18B | $2.33B | $1.56B |
Cash & Equivalents | $599.40M | $368.20M | $620.50M | $724.10M |
Free Cash Flow OCF − CapEx | $202.70M | $-99.70M | $-428.60M | $-80.00M |
Shares Outstanding | 69.20M | 71.00M | 72.40M | 75.20M |